| Primary |
| Osteoporosis Postmenopausal |
53.3% |
| Osteoporosis |
12.9% |
| Hypertension |
7.3% |
| Prophylaxis |
2.8% |
| Constipation |
2.2% |
| Back Pain |
1.9% |
| Chronic Hepatitis |
1.9% |
| Hyperlipidaemia |
1.9% |
| Fracture |
1.6% |
| Gastric Ulcer |
1.6% |
| Oedema Peripheral |
1.6% |
| Osteoarthritis |
1.6% |
| Asthma |
1.3% |
| Diabetes Mellitus |
1.3% |
| Gastritis |
1.3% |
| Hepatitis C |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Reflux Oesophagitis |
1.3% |
| Cough |
0.9% |
| Insomnia |
0.9% |
|
| Cerebral Infarction |
9.7% |
| Death |
8.3% |
| Femoral Neck Fracture |
6.9% |
| Ovarian Cancer Recurrent |
6.9% |
| Spinal Compression Fracture |
6.9% |
| Breast Cancer Female |
5.6% |
| Large Intestine Carcinoma |
5.6% |
| No Adverse Effect |
5.6% |
| Paraesthesia |
5.6% |
| Rib Fracture |
5.6% |
| Heat Stroke |
4.2% |
| Oedema Peripheral |
4.2% |
| Pneumonitis |
4.2% |
| Sepsis |
4.2% |
| Alopecia Areata |
2.8% |
| Angina Pectoris |
2.8% |
| Chest Pain |
2.8% |
| Colon Cancer |
2.8% |
| Hallucination |
2.8% |
| Humerus Fracture |
2.8% |
|
| Secondary |
| Osteoporosis |
23.1% |
| Osteoporosis Postmenopausal |
17.4% |
| Prophylaxis |
9.9% |
| Fracture |
9.1% |
| Hypertension |
8.3% |
| Cough |
5.0% |
| Hepato-lenticular Degeneration |
5.0% |
| Hypertriglyceridaemia |
3.3% |
| Osteoarthritis |
3.3% |
| Menopause |
2.5% |
| Mood Altered |
2.5% |
| Musculoskeletal Pain |
2.5% |
| Gastritis |
1.7% |
| Irritable Bowel Syndrome |
1.7% |
| Autoimmune Thyroiditis |
0.8% |
| Cellulitis |
0.8% |
| Gastric Ulcer |
0.8% |
| Hypercalcaemia |
0.8% |
| Hypothyroidism |
0.8% |
| Nail Tinea |
0.8% |
|
| Paraesthesia |
22.2% |
| Transient Ischaemic Attack |
8.3% |
| Femur Fracture |
5.6% |
| Humerus Fracture |
5.6% |
| Monoparesis |
5.6% |
| Patella Fracture |
5.6% |
| Pleurisy |
5.6% |
| Renal Impairment |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Aortic Thrombosis |
2.8% |
| Carpal Tunnel Syndrome |
2.8% |
| Low Turnover Osteopathy |
2.8% |
| Milk-alkali Syndrome |
2.8% |
| Mitral Valve Incompetence |
2.8% |
| Pathological Fracture |
2.8% |
| Physical Disability |
2.8% |
| Pulmonary Fibrosis |
2.8% |
| Rash |
2.8% |
| Rash Morbilliform |
2.8% |
| Tachycardia |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.8% |
| Product Used For Unknown Indication |
18.2% |
| Rheumatoid Arthritis |
13.1% |
| Osteoporosis |
4.2% |
| Depression |
3.4% |
| Hypertension |
3.0% |
| Pain |
2.6% |
| Psoriatic Arthropathy |
2.6% |
| Acute Myeloid Leukaemia |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Hypothyroidism |
1.8% |
| Cardiac Disorder |
1.5% |
| Prophylaxis |
1.4% |
| Mineral Supplementation |
1.3% |
| Osteoporosis Prophylaxis |
1.3% |
| Bone Disorder |
1.2% |
| Bronchiectasis |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.2% |
| Lipid Metabolism Disorder |
1.0% |
| Premedication |
1.0% |
|
| Vomiting |
10.2% |
| Cellulitis |
6.8% |
| Pruritus |
6.8% |
| Urinary Tract Infection |
6.8% |
| Weight Decreased |
6.8% |
| Weight Increased |
6.8% |
| Arrhythmia |
4.5% |
| Death |
4.5% |
| Hypokalaemia |
4.5% |
| Pain In Extremity |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Skin Burning Sensation |
4.5% |
| Vaginal Discharge |
4.5% |
| Anaphylactic Shock |
3.4% |
| Arthropathy |
3.4% |
| Fall |
3.4% |
| Hot Flush |
3.4% |
| Hypophosphataemia |
3.4% |
| Malaise |
3.4% |
| Nausea |
3.4% |
|
| Interacting |
| Hypertension |
25.0% |
| Breast Cancer |
16.7% |
| Prophylaxis |
16.7% |
| Alopecia |
8.3% |
| Gastrooesophageal Reflux Disease |
8.3% |
| Rheumatoid Arthritis |
8.3% |
| Vitamin Supplementation |
8.3% |
| Hypertriglyceridaemia |
4.2% |
| Osteoporosis Prophylaxis |
4.2% |
|
| Influenza Like Illness |
66.7% |
| Investigation Abnormal |
33.3% |
|
